Conway Regional Health System

PurposeFor decades, organizational research has primarily considered instrumental technology perceptions (ITP) – emphasizing how technology impacts the personal interests of end users themselves – to understand technology acceptance. The authors offer a complementary paradigm by introducing deontic technology perceptions (DTP), defined as the degree to which individuals believe that the technology they use is beneficial to other individuals beyond themselves (e.g. beneficial to customers).Design/methodology/approachThe authors collected quantitative survey-based data from three different hospitals located in the United States. On the basis of conservation of resources theory, the authors investigated whether both DTP and ITP were associated with improved work-related well-being.FindingsTwo pilot studies (n = 161 and n = 311 nurses) substantiated our DTP conceptualization. Our primary study (n = 346 nurses) found support for the association between DTP and improved work-related well-being. Evidence for the relationship between ITP and work-related well-being was mixed and the authors did not find a statistically significant interaction between DTP and ITP.Originality/valueThe authors build on decades of research on technology acceptance by complementing it with our deontic perspective. Our work demonstrates that technology users pay attention and react meaningfully to how their use of technology impacts not only themselves but also external parties like patients, customers and members of the general public.

BackgroundHuman Rhinovirus (hRV) causes mild, primarily upper respiratory tract symptoms in immunocompetent hosts. However, in immunocompromised patients, it often progresses to a lower respiratory tract infection. Multiple myeloma (MM) patients are immunocompromised due to inherent immunodeficiency and exposure to biologic and chemotherapeutic agents. The complications of hRV infection in MM patients are not well known. In this study, we aim to identify the morbidity and mortality associated with hRV in MM participants.MethodsThis was a retrospective study, using Arkansas Clinical Registry Database, which identified all MM patients diagnosed with hRV infection by nasopharyngeal multiplex polymerase chain reaction (PCR) in January-December 2019. Duplicates within 30 days were excluded. Patients were followed for 30 days after diagnosis. We assessed the need for hospitalization, intensive care unit (ICU) admission, oxygen administration, mechanical ventilation, and death. We collected their absolute neutrophil (ANC) and lymphocyte count (ALC) within three days of diagnosis and compared values using Mann-Whitney U test.ResultsWe identified 217 MM patients with hRV. Ninety (41%) had prior autologous stem cell transplant, 148 (68%) had received chemotherapy within 30 days. Ninety (41%) had chest imaging, with 11 (12%) having infiltrates. Out of the 217, 69 (31.9%) were admitted, with a mean length of stay of 3 days. 13% of the admitted patients were transferred to the ICU. 65.5% of the admitted patients needed oxygen, and two required mechanical ventilation. The mean ANC and ALC for the admitted group was 3.88 cells/µL and 1.22 cells/µL respectively, compared to 3.57 cells/µL and 1.07 cells/µL in the outpatient group, p=0.6 and 1. Five participants died.ConclusionHuman Rhinovirus infection in MM patients was associated with significant morbidity, including hospitalization, ICU care, supplemental oxygen requirement, and even mechanical ventilation in 2 patients. Death was observed within 30 days, although rarely. The mean ALC and ANC were not predictive of the severity of the disease. Recognizing hRV effects on morbidity and mortality could lead to earlier recognition and management of complications in MM patients.DisclosuresAll Authors: No reported disclosures

BackgroundThe current standard of care for multiple myeloma (MM) patients is to administer the influenza vaccine (InfV) annually. While in immunocompetent patients, the influenza vaccine is associated with significant benefit in morbidity and mortality, the inherent immunodeficiency from MM and its treatments reduce the InfV efficacy but it is thought to have some benefit. The effect on morbidity and mortality in MM patients has not been evaluated. Our study aims to investigate whether InfV vaccination status affects outcomes of MM patients diagnosed with Influenza A or B (FluA, FluB). MethodsThis was a retrospective study, using Arkansas Clinical Data Repository, which identified all MM patients diagnosed with FluA or FluB during five consecutive flu seasons from September 1st to April 30th, 2015-2020. Those with hospital-acquired influenza were excluded. The outcome data were collected for 30 days following the initial diagnosis. Fisher Exact test was used to compare categorical variables, and Mann Whitney U test to compare continuous variables. ResultsWe identified 194 MM patients diagnosed with FluA or FluB. Sixty-five (34%) were vaccinated and 129 (66%) were not vaccinated. A total of 87 (45%) were admitted to the hospital. Twenty-five (38%) of the vaccinated vs. 62 (48%) of the unvaccinated group were hospitalized (p=0.22), and 4/65 vaccinated vs. 12/129 unvaccinated required ICU treatment (p=0.59). Two patients in the vaccinated and 3 in the non-vaccinated group were intubated (p=1). The mean length of stay (LOS) for the vaccinated and unvaccinated was 10 days and 14 days, respectively, which was not significantly different (p=0.197). Two (3%) patients died within 30 days of diagnosis in the vaccinated group while four (3%) died in the unvaccinated group (p=1).ConclusionThe InfV status of MM patients had no effect on outcomes including the need for hospital admission, ICU stay, mechanical ventilation, LOS, and death. Hospitalization was common, but severe illness requiring ICU care and intubation were less common. Six patients died within 30 days of influenza diagnosis. Vaccination strategy, including high-dose and repeat doses, should be examined in MM patients. DisclosuresAll Authors: No reported disclosures

“How could I apply this information?” Previous literature outlines the optimal outcomes of functional training based on principles of motor learning.1 Through a national survey among Norwegian physical therapists, this method was reported as the primary method of choice when treating children with cerebral palsy whose goals are to learn gross motor skills. A larger proportion of therapists selected functional training based on principles of motor learning than those in previous studies, suggesting the gap is closing between what is known to be efficacious and what is implemented. Because of the required high frequency of skill practice with this method, the continued need for strong teaming between the therapist, parents, and school personnel is essential to allow for continued practice outside of the therapy session. Integral to the team approach are much-needed conversations with therapists and parents about physical therapy practice and evidence-based outcomes related to the method of choice.1 Of interest, the physical therapists with the most experience had statistically significantly less probability of using functional training based on principles of motor learning than physical therapists with less experience. This finding suggests that knowledge translation within the field of pediatric physical therapy practice is a continued need. “What should I be mindful about when applying this information?” The study used a convenience sample from the Association of Physiotherapists in Norway (65% response rate) that may not be truly representative of the entire group of practicing pediatric physical therapists in Norway. Future studies investigating responses from physical therapists who are not association members could further inform knowledge translation efforts. Additional studies to assess practice through observation, clinician self-reflection, or parent report are needed to determine what percentages of practice approaches are actually being implemented rather than reported in each session. Leah M. Lowe, PT, DPT, PhD, PCS Department of Physical Therapy University of Central Arkansas Conway Deandriea Bass-Carrigan, PhD, LAC, CRC Arkansas Rehabilitation Services Conway Charlotte C. Yates, PT, PhD, PCS Department of Physical Therapy University of Central Arkansas Conway

Five of 13 patients with microphthalmia or clinical anophthalmia studied in an institution of 650 mentally retarded adults had hypogonadotropic hypogonadism. Four males had low testosterone levels and sexual infantilism, manifesting as micropenis with small testes or cryptorchidism. One female had primary amenorrhea. All 5 patients had low gonadotropin levels, confirming a hypothalamic or pituitary basis for their hypogonadism. Thyroxin, thyroid stimulating hormone, prolactin, and A.M. cortisol were also measured and were normal. All patients with hypogonadotropic hypogonadism were chromosomally normal and had variable central nervous system defects, suggesting that they comprise a heterogeneous group of disorders. Microphthalmia or anophthalmia in a mentally retarded patient is associated with hypogonadotropic hypogonadism.

Abstract Current methods of determining the specific gravity, moisture content, and absorption of concrete aggregates (ASTM Test Method for Specific Gravity and Absorption of Coarse Aggregate [C 127], ASTM Test Method for Specific Gravity and Absorption of Fine Aggregate [C 128], and ASTM Test Method for Total Moisture Content of Aggregate by Drying [C 566]) are slow and dependent upon subjective “end-point” determinations as well as requiring elaborate and cumbersome equipment. Presented here is a method using simple equipment, the siphon can, to accomplish all three tests. This technique has an objective “end-point” and statistical error of measurement one-quarter that of ASTM C 127 or C 128. Derivation of formulae and method of application are discussed. The use of this technique in routine concrete production can result in large savings to concrete producers.